Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01683630Completed

Comparison of Epidemiology and Clinical Outcomes of Influenza A & B Cases in Manitoba, Canada

Role: lead

NCT01421251Unknown

H1N1 Vaccine Safety in Manitoba, Canada

Role: lead

NCT01622491Unknown

Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada

Role: lead

All 3 trials loaded